HK1251265A1 - 感染性疾病的診斷與治療 - Google Patents

感染性疾病的診斷與治療

Info

Publication number
HK1251265A1
HK1251265A1 HK18110713.5A HK18110713A HK1251265A1 HK 1251265 A1 HK1251265 A1 HK 1251265A1 HK 18110713 A HK18110713 A HK 18110713A HK 1251265 A1 HK1251265 A1 HK 1251265A1
Authority
HK
Hong Kong
Prior art keywords
diagnosis
treatment
infectious disease
infectious
disease
Prior art date
Application number
HK18110713.5A
Other languages
English (en)
Inventor
Helen Lee
Michael Powell
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1510876.4A external-priority patent/GB201510876D0/en
Priority claimed from GBGB1609529.1A external-priority patent/GB201609529D0/en
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Publication of HK1251265A1 publication Critical patent/HK1251265A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18110713.5A 2015-06-19 2018-08-21 感染性疾病的診斷與治療 HK1251265A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1510876.4A GB201510876D0 (en) 2015-06-19 2015-06-19 Diagnosis and treatment of infectious disease
GBGB1609529.1A GB201609529D0 (en) 2016-05-31 2016-05-31 Diagnosis and treatment of infectious disease
PCT/GB2016/051831 WO2016203267A2 (en) 2015-06-19 2016-06-17 Diagnosis and treatment of infectious disease

Publications (1)

Publication Number Publication Date
HK1251265A1 true HK1251265A1 (zh) 2019-01-25

Family

ID=56684680

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110713.5A HK1251265A1 (zh) 2015-06-19 2018-08-21 感染性疾病的診斷與治療

Country Status (8)

Country Link
US (1) US20180355410A1 (zh)
EP (1) EP3310929A2 (zh)
JP (3) JP2018518180A (zh)
CN (1) CN108026581A (zh)
AU (2) AU2016278110A1 (zh)
HK (1) HK1251265A1 (zh)
WO (1) WO2016203267A2 (zh)
ZA (1) ZA201800037B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202102098WA (en) * 2018-09-03 2021-04-29 Visby Medical Inc Devices and methods for antibiotic susceptibility testing
GB201902887D0 (en) 2019-03-04 2019-04-17 St Georges Hospital Medical School Detection and antibiotic resistance profiling of microorganisms
US20220175791A1 (en) * 2019-04-18 2022-06-09 The Regents Of The University Of California Methods for Predicting Neisseria Spp. Susceptibility to Cefixime
CN110643722A (zh) * 2019-09-10 2020-01-03 中国医学科学院病原生物学研究所 一种淋病奈瑟菌耐药位点多重检测方法及试剂盒
JP7387357B2 (ja) 2019-09-26 2023-11-28 直 早川 淋菌のdnaジャイレースのサブユニットaの83番目のアミノ酸をコードする塩基配列における変異の有無を検出するためのプライマーセット、淋菌のフルオロキノロンに対する感受性の有無を評価するためのプライマーセット、及びそれらの使用
EP4085149A4 (en) 2020-01-03 2024-03-06 Visby Medical Inc ANTIBIOTIC SUSCEPTIBILITY TESTING DEVICES AND METHODS
CN111394438A (zh) * 2020-01-19 2020-07-10 中国医学科学院病原生物学研究所 一种淋病奈瑟菌耐药位点多重检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
JP4558105B2 (ja) * 1994-06-09 2010-10-06 イノジェネティックス・ナムローゼ・フェンノートシャップ ミコバクテリウム種の抗生物質耐性スペクトルの検出方法
US6706475B1 (en) * 1998-04-01 2004-03-16 The United States Of America As Represented By The Department Of Health And Human Services Oligonucleotide probes for detecting Enterobacteriaceae and quinolone-resistant Enterobacteriaceae
JP2001103981A (ja) * 1999-08-03 2001-04-17 Nisshinbo Ind Inc 結核菌診断キット
GB0016836D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
GB0016833D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (2)
GB0016813D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (4)
CN1246474C (zh) * 2001-07-13 2006-03-22 刘元 采用基因芯片技术检测耐药基因
US7820378B2 (en) * 2002-11-27 2010-10-26 Sequenom, Inc. Fragmentation-based methods and systems for sequence variation detection and discovery
TWI349704B (en) * 2004-08-10 2011-10-01 Food And Drug Administration Dept Of Health A method for rapidly detecting quinolone-resistant salmonella spp. and the probes and primers utilized therein
GB0428255D0 (en) * 2004-12-23 2005-01-26 Health Prot Agency Detection of nucleic acid mutations
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
ES2582602T3 (es) * 2007-03-28 2016-09-14 Signal Diagnostics Sistema y método de análisis de alta resolución de ácidos nucleicos para detectar variaciones de secuencia
KR101374045B1 (ko) * 2011-11-17 2014-03-14 솔젠트 (주) 중합효소연쇄반응을 이용한 생물학적 시료내에서 퀴놀론 내성 캠필로박터균을 검출하는 방법 및 이에 사용되는 키트

Also Published As

Publication number Publication date
WO2016203267A2 (en) 2016-12-22
EP3310929A2 (en) 2018-04-25
CN108026581A (zh) 2018-05-11
JP2018518180A (ja) 2018-07-12
US20180355410A1 (en) 2018-12-13
AU2016278110A1 (en) 2018-02-01
WO2016203267A3 (en) 2017-02-16
JP2024019730A (ja) 2024-02-09
ZA201800037B (en) 2022-04-28
JP2021072868A (ja) 2021-05-13
AU2022206701A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
HK1251257A1 (zh) 用於醫治疾病的外泌體的用途
HK1215142A1 (zh) 多光譜醫學成像裝置及其方法
PT3212233T (pt) Terapia combinada para o tratamento de doenças
HK1253769A1 (zh) 用於診斷和治療腎上腺腦白質營養不良的方法和組合物
HK1251265A1 (zh) 感染性疾病的診斷與治療
EP2968397A4 (en) DIAGNOSIS AND TREATMENT OF FIBROSIS
GB201504432D0 (en) Materials and methods for diagnosis and treatment of alzheimers disease
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
SG11201707816PA (en) Patient interface and aspects thereof
IL275368B (en) Diagnosis and treatment of autoimmune diseases
SG11201703704PA (en) Diagnosis and treatment of incipient diabetes
EP3130582B8 (en) Compound having immune disease treatment effect and use thereof
ZA201902385B (en) Compounds and methods for diagnosis and treatment of viral infections
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
EP3831844C0 (en) DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS
HK1255691A1 (zh) 對疾病進行組織學診斷和治療的方法
SG11201605440TA (en) Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
IL248935A0 (en) Diagnostic testing and treatment/prevention of Alzheimer's disease
GB201515244D0 (en) Treatment of inflammatory disease or condition
LT3137093T (lt) Alzheimerio ligos (ad) gydymas ir prevencija
HK1251021A1 (zh) 診斷和治療mers相關腎病
EP2943593A4 (en) DIAGNOSIS AND TREATMENT OF VIRUS DISEASES
GB201500875D0 (en) Antibodies for treatment and diagnosis
HK1257598A1 (zh) 改善心臟病變的藥物及其用途
IL256812A (en) Heteroaryl carbonitriles for the treatment of disease